Changes in Epithelial Ovarian Cancer Recurrence and Survival According to Treatment Paradigm Shifts. [PDF]
ABSTRACT Aim To evaluate oncologic outcomes in patients with epithelial ovarian cancer (EOC) amid evolving surgical and systemic therapy paradigms. Methods This retrospective cohort study included patients diagnosed with EOC from June 2003 to December 2020 at a single tertiary center, grouped by diagnosis period.
Kim J, Suh DH, Kim K, No JH, Kim YB.
europepmc +2 more sources
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort Study. [PDF]
ABSTRACT Background and Objective Stage IVB high‐grade serous ovarian cancer (HGSOC) carries a poor prognosis. We aimed to: (1) describe the characteristics and survival of patients treated with primary cytoreductive surgery (PCS), interval cytoreductive surgery (ICS) or chemotherapy alone, (2) investigate the correlation between disease distribution ...
Benseler A +6 more
europepmc +2 more sources
Robotic assisted cytoreductive surgery, removal of a recurrent disease in the right pericaval lymph node in a patient with ovarian cancer with the robotic Xi platform [PDF]
Objective The standard approach for recurrent ovarian cancer is laparotomy. In this video, we present a cytoreductive surgery using the robotic Xi platform to remove a 2.7 cm pericaval tumor.
Massoud Shoraka +3 more
doaj +1 more source
Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer- a retrospective cohort study [PDF]
Background/Aim. The gold standard in treating the advanced ovarian cancer (AOC) is primary debulking surgery (PDS) followed by platinum-based adjuvant chemotherapy.
Maričić Slobodan +7 more
doaj +1 more source
Gastropleural fistula following advanced stage ovarian cancer interval cytoreductive surgery: A case report and review of the literature [PDF]
Introduction: Gastropleural fistula (GPF) is an exceptionally rare complication in oncologic surgery, most often reported after thoracic or abdominal procedures and only sporadically described in ovarian cancer.
Sofia Bigardi +7 more
doaj +2 more sources
Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis [PDF]
The oncologic outcomes of cytoreductive prostatectomy (CRP) in oligometastatic prostate cancer (OmPCa) are still controversial. Therefore, we conducted a systematic review and meta-analysis on the oncologic outcome of CRP in OmPCa.
Doo Yong Chung +7 more
doaj +1 more source
Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer [PDF]
From the perspective of survival outcomes, the cancer survival of colorectal cancer (CRC) in the whole stage has improved. Peritoneal metastasis (PM) is found in approximately 8% to 15% of patients with CRC, with a poorer prognosis than that associated ...
Young Jin Kim, Chang Hyun Kim
doaj +1 more source
Ovarian cancer (OC) is the fifth most common cause of death in women and accounts for more deaths than any other cancer of the female reproductive tract. OC usually spreads through peritoneal dissemination and direct invasion. Optimal cytoreduction (no macroscopic residual disease) and adjuvant platinum-based chemotherapy are the fundaments of OC ...
Kostov, Stoyan +5 more
openaire +3 more sources
Objective. To estimate the results of peritoneoectomy and multiorgan resection in the treatment of prevalent tumors of abdominal cavity and small pelvis. Materials and methods.
O. I. Тkachenko +5 more
doaj +1 more source
Background Jejunal lymphatic malformations are congenital lesions that are seldom diagnosed in adults and rarely seen on imaging. Case presentation A 61-year-old Caucasian woman was initially diagnosed and treated for mucinous ovarian carcinoma. After an
Mark Rupasinghe +6 more
doaj +1 more source

